DELEE
Delee is a medical device company that aims to revolutionize how cancer is diagnosed and managed. That is why we developed CytoCatch™, a patent-pending technology that enables the performance of a CTC blood-based assay that has the potential of being used for early cancer detection and monitoring of the applied treatments’ effectiveness. This technology consists of an isolation platform, which automatically performs the necessary steps to process the sample, capturing the CTCs contained in ... it, and an imaging system, which possesses special routines and machine learning algorithms that analyze the captured cells based on their morphology and the expression of specific markers. The fact that all these processes are fully automated increases the reliability and reproducibility of the assay by preventing human errors and cell loss due to manual steps. Furthermore, the collected cells are compatible with traditional molecular biology techniques and next-generation technologies, enabling the performance of molecular analysis to assess the genetic characteristics of the captured CTCs. This innovative technology will enable a broad range of cancer-related clinical applications.
DELEE
Industry:
Health Care Health Diagnostics Medical Device Product Research
Founded:
2016-11-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.delee.co
Total Employee:
11+
Status:
Active
Contact:
+1 956 662 4893
Email Addresses:
[email protected]
Total Funding:
2.37 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content DigiCert SSL Encryption Everywhere Sedo Hosting
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
The International Agency for Research on Cancer
The International Agency for Research on Cancer is the specialized cancer agency of the World Health Organization.
Viz
Viz is a medical imaging company that provides an AI-based care coordination tool for disease detection and workflow optimization.
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Seed Round - Delee
Newest Events participated
Participated in Y Combinator Winter 2017 Demo Day
on 2017-03-20 as exhibitor
Official Site Inspections
http://www.delee.co Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Delee"
Delee - Crunchbase Company Profile & Funding
Delee is a medical device company that aims to revolutionize how cancer is diagnosed and managed. That is why we developed CytoCatchâ„¢, a patent-pending technology that enables the performance of a CTC blood-based …See details»
Delee Company Profile 2024: Valuation, Funding
Delee General Information Description. Operator of a technology company intended to specialize in biotech and medical device automation. The company's technology enables the performance of a Circulating-Tumour-Cells (CTC) …See details»
Delee Corp - LinkedIn
Delee is a medical device company that has developed two devices: the CytoCatchâ„¢ Isolation Platform and the CytoCatchâ„¢ Imaging System, for isolating and analyzing circulating tumor cells (CTCs ...See details»
Delee - Products, Competitors, Financials, Employees, …
Led by 26-year-old Liza Velarde, Co-founder and CEO, Delee has developed a circulating tumor cell (CTC) detection technology (CytoCatchTM) involving a simple blood test and lab-on-a-chip …See details»
Delee - Y Combinator
Co-Founder and acting CEO at Delee Corp. Velarde has been responsible for the development and execution of the company's strategic plans. Velarde's outstanding work has been highly …See details»
Delee Company Profile - Office Locations, Competitors, Revenue
Delee is a medical device company that develops imaging systems. It offers the CytoCatch Isolation, a platform that automates and performs the collected cells with fluorescently labeled …See details»
Delee - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Liza Velarde - Co-Founder, Director, & CEO @ Delee - Crunchbase
Liza Velarde is the Co-Founder, Director, and CEO at Delee Corp. Velarde is a Y Combinator alumna, and received a Bachelor of International Business degree, summa cum laude, from …See details»
Delee Co-Founder Liza Velarde on Improving and ... - Kingscrowd
Nov 5, 2021 Delee is a company specializing in the development of medical devices. However, from the beginning, our main focus has been to create an innovative technology that allows …See details»
Delee - AMH Fund
Delee is a Texas-based company dedicated to changing the way cancer is detected, monitored, and treated to increase patients’ chances of defeating the disease. Delee was founded by …See details»
Hispanic Female Founder Raises $1 Million Via Reg CF To ... - Forbes
Jul 1, 2020 The Delee co-founders realized it needed more money to pursue FDA approval of the device, test if CytoCatch works with other cancers, and ensure that health insurance will …See details»
Delee - Republic
Delee – Medical technology for early cancer detection and treatment monitoring – is now accepting investments on Republic. ... according to the World Health Organization (WHO), …See details»
Delee - The Ganesha Lab
Delee. delee.co; LinkedIn « Back to Portfolio. A true revolution in blood tests for cancer detection with cutting-edge technology capable of efficiently isolating and analyzing CTCs from blood. Its …See details»
Delee, transforming cancer detection and treatment - ResearchGate
Apr 25, 2021 Liza Velarde, Delee’s CEO, was preparing the agenda for the company’s 2025 planning in November 2020. The journey has been challenging, and Liza Velarde faced critical …See details»
Cytocatch Isolation Platform - Delee Corp
The Cytocatch Isolation Platform is a device developed to capture circulating tumor cells contained in a blood sample without human intervention. The captured cells are compatible …See details»
Delee - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Delee . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Delee has 3 current employee profiles, including Chief …See details»
Delee Corp | Sunnyvale CA - Facebook
Delee Corp, Sunnyvale, California. 554 likes. Delee is a medical device company that developed a screening test for cancer therapy management that will allow physicians to do early diagnosis at a...See details»
Delee, transforming cancer detection and treatment
Oct 7, 2021 Delee founders aimed to change the way cancer radically was detected, monitored, and treated. They created CytoCatchâ„¢, a highly sensitive automated benchtop device for the …See details»
Technology - Delee Corp
Circulating Tumor Cells (CTCs) are malignant cells that are shed from the primary or metastatic solid tumors and then infiltrate into the vascular and lymphatic systems; these cells play a …See details»